Gjertson D W, Cecka J M
The United Network for Organ Sharing (UNOS), Scientific Renal Transplant Registry and the Department of Pathology, University of California, Los Angeles, USA.
Pediatr Transplant. 2001 Feb;5(1):5-15. doi: 10.1034/j.1399-3046.2001.00137.x.
Pediatric 1-yr kidney graft survival rates have steadily improved in the US so that, by 1998, over 90% of hospital-discharged young recipients had survived the first year post-transplantation (Tx). However, 25% of the early surviving kidney grafts failed at 5 yr, yielding a projected half-life of 10 yr. Given a median age at transplant of 13 yr (range 0-20 yr), 50% of all current pediatric kidney recipients will need a second graft before the age of 25 years. We examined 8,422 pediatric renal transplants reported to the United Network for Organ Sharing (UNOS) Kidney Transplant Registry and, by using a log-linear multifactorial analysis, determined the relative influence of 26 major transplant factors on long-term graft survival. Results are reported as percentages of assignable variation (totaling 100% for all 26 factors combined) in pediatric outcomes beyond 1 yr and as adjusted graft survival rates. Transplant center, recipient race and age, transplant year, and panel-reactive antibody (PRA) had assignable variation percentages of 25, 24, 16, 12, and 4, respectively. When combined, they accounted for 81% of changes in long-term survival. Besides center effects, Blacks, teenagers, and transplants performed before 1994 exhibited significantly (p <0.0001) lower adjusted 5-yr graft survival rates as did the few sensitized (PRA>40%) pediatric patients (p = 0.02). Patients transplanted with a living donor kidney demonstrated a 5% point advantage at 5 yr post-Tx over cadaver donor kidneys (p = 0.001). Although the survival rate of pediatric kidney transplants has improved steadily, the long-term outcomes for teenagers and for Black recipients lag significantly behind those of younger patients and non-Blacks.
在美国,小儿肾移植1年生存率稳步提高,到1998年,超过90%的出院年轻受者在移植后第一年存活。然而,25%的早期存活肾移植在5年时失败,预计半衰期为10年。鉴于移植时的中位年龄为13岁(范围0 - 20岁),所有目前的小儿肾移植受者中有50%将在25岁之前需要第二次移植。我们检查了向器官共享联合网络(UNOS)肾移植登记处报告的8422例小儿肾移植病例,并通过对数线性多因素分析,确定了26个主要移植因素对长期移植存活的相对影响。结果以小儿移植后1年以上结局中可归因变异的百分比(所有26个因素相加总计100%)以及调整后的移植存活率报告。移植中心、受者种族和年龄、移植年份以及群体反应性抗体(PRA)的可归因变异百分比分别为25%、24%、16%、12%和4%。综合起来,它们占长期存活变化的81%。除了中心效应外,黑人、青少年以及1994年之前进行的移植,其调整后的5年移植存活率显著较低(p <0.0001),少数致敏(PRA>40%)的小儿患者也是如此(p = 0.02)。接受活体供肾移植的患者在移植后5年比尸体供肾移植患者有5个百分点的优势(p = 0.001)。尽管小儿肾移植的存活率稳步提高,但青少年和黑人受者的长期结局明显落后于年轻患者和非黑人受者。